Krebs Biochemicals & Industries (NSE:KREBSBIO) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KREBSBIO Krebs Biochemicals & Industries Ltd NSE:KREBSBIO
45 GF Score
Price ₹55.95
GF Value ₹42.89
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Krebs Biochemicals & Industries FFO?

FFO (Funds from operations) only applies to REITs.

NSE:KREBSBIO
45GF Score
Krebs Biochemicals & Industries Ltd NSE:KREBSBIO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Krebs Biochemicals & Industries (NSE:KREBSBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Krebs Biochemicals & Industries stock appears to be overvalued. The current stock price of ₹55.95 is trading 30.4% above its estimated GF Value™ of ₹42.89. GuruFocus considers Krebs Biochemicals & Industries to be Significantly Overvalued.

Key valuation signals for NSE:KREBSBIO:

  • FFO:
  • GF Value™: ₹42.89 vs. price of ₹55.95 (30.4% above fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the NSE:KREBSBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krebs Biochemicals & Industries Business Description

Other Exchanges 524518:India
Address Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, AP, IND, 531 031
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.
45GF Score

Get the complete analysis for NSE:KREBSBIO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹55.95
Price
₹42.89
GF Value